Chopas James George

CIK 00018364302 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001836430

Recent Transactions

50 trades

Disposition from Tender
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−65,955→ 0 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14+5,625→ 5,625 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−5,625→ 0 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14+8,394→ 8,394 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−8,394→ 0 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14+16,150→ 16,150 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−16,150→ 0 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14+8,075→ 8,075 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−8,075→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−2,406→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−4,156→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−9,444→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−16,150→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-05-14−6,250→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−11,250→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−20,853→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−15,114→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−12,086→ 0 total
Disposition to Issuer
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (right to buy)
2026-05-14−21,750→ 0 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-01-28+16,150→ 65,955 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-01-22$21.77/sh−2,064→ 49,805 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2026-01-20$19.79/sh−726→ 51,869 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-09-15$24.19/sh−189→ 53,468 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-09-02$28.08/sh−548→ 53,657 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-06-18+6,250→ 54,205 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2025-06-09$19.39/sh+11,250→ 11,250 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-03-17$24.82/sh−183→ 47,955 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-01-22$30.43/sh−1,096→ 48,138 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-01-21+12,591→ 49,234 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-01-17$29.96/sh−715→ 36,643 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2025-01-13$28.70/sh−783→ 37,358 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-09-16$36.21/sh−192→ 38,141 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-09-03$39.49/sh−550→ 38,333 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-03-15$56.46/sh−184→ 38,883 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-22$65.00/sh−1,061→ 39,067 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2024-01-16$66.30/sh+12,086→ 12,086 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-16+8,312→ 40,992 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2024-01-16$66.81/sh−864→ 40,128 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-10-23$46.04/sh−132→ 32,680 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-09-14+2,500→ 32,812 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-08-31$41.23/sh−551→ 30,312 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-02-21+5,737→ 5,737 total
Tax Payment
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-02-21$58.50/sh−334→ 30,863 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-02-21+4,044→ 31,197 total
Tax Payment
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-01-20$52.05/sh−919→ 27,153 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-01-12+9,621→ 28,072 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-01-12$52.66/sh+15,114→ 15,114 total
Tax Payment
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-10-20$58.00/sh−130→ 18,451 total
Tax Payment
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-08-30$58.84/sh−558→ 18,581 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-01-21+6,974→ 15,456 total

Companies

Recent Filings

Address

C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR

WALTHAM, MA, 02451

View on SEC.gov